Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

German launch for Eisai/Pfizer Alzheimer's Rx

Nov. 25, 1997

Synthelabo's Solian introduced in U.K.

Nov. 25, 1997

New valproic acid analogue selected as candidate anticonvulsant

Nov. 25, 1997

Sankyo discloses inositol 1,4,5-triphosphate inhibitors

Nov. 25, 1997

SKB describes novel 5-HT1B antagonists

Nov. 25, 1997

Muscarinic cholinergic agonists disclosed by Novo Nordisk

Nov. 25, 1997

Toray/Daiichi to begin clinical development of non-narcotic analgesic

Nov. 25, 1997

Gel formulation of diclofenac and hyaluronan effective in aphthous ulcer pain

Nov. 24, 1997

Brain GABA receptor ligands prepared at Neurogen

Nov. 24, 1997

Update on pagoclone

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...